| Organism name | Lycium chinense |
|---|---|
| Genus | Lycium |
| Family | Solanaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Lycium chinense |
|---|---|
| Linked NCBI taxonomy ID | 112883 |
| Linked level | species |
| Family in NCBI taxonomy | Solanaceae |
|---|---|
| ID | 4070 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | asterids |
|---|---|
| ID | 71274 |
| Species | Activity |
|---|---|
| Lycium chinense Mill. | ACE Inhibitor |
| Lycium chinense Mill. | Analgesic |
| Lycium chinense Mill. | Antiaging |
| Lycium chinense Mill. | Antibacterial |
| Lycium chinense Mill. | Antipyretic |
| Lycium chinense Mill. | Bitter |
| Lycium chinense Mill. | Depurative |
| Lycium chinense Mill. | Hemostat |
| Lycium chinense Mill. | Hepatoprotective |
| Lycium chinense Mill. | Hepatotonic |
| Lycium chinense Mill. | Hypoglycemic |
| Lycium chinense Mill. | Hypotensive |
| Lycium chinense Mill. | Immunosuppressive |
| Lycium chinense Mill. | Mydriatic |
| Lycium chinense Mill. | Nephrotonic |
| Lycium chinense Mill. | Radioprotective |
| Lycium chinense Mill. | Tonic |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00036313
|
(+)-Lyoniresinol 3alpha-O-beta-glucopyranoside
/ (+)-Lyoniresinol 3alpha-O-beta-D-glucopyranoside |
CHEMBL464198
CHEMBL1159486 CHEMBL1159487 CHEMBL1813178 CHEMBL1813179 CHEMBL1813180 CHEMBL1813181 CHEMBL2332109 |
6 / 11 / 5 | No. 174 | No. 22 |
|
||
|
C00036866
|
Calystegine B4
|
CHEMBL526330
CHEMBL513797 CHEMBL1213469 CHEMBL1984376 |
1 / 6 / 4 | No. 643 | No. 1 |
|
||
|
C00036868
|
Calystegine C1
/ (+)-Calystegine C1 |
CHEMBL1972699
|
No. 643 | No. 1 |
|
|||
|
C00028001
|
Calystegine B1
|
CHEMBL1965915
|
C110567
|
No. 643 | No. 1 |
|
||
|
C00036867
|
Calystegine B5
/ (+)-Calystegine B5 |
No. 643 | No. 1 |
|
||||
|
C00036870
|
Calystegine N1
|
No. 643 | No. 1 |
|
||||
|
C00035552
|
Calystegine B3
/ (+)-Calystegine B3 |
CHEMBL526330
CHEMBL513797 CHEMBL1213469 CHEMBL1984376 |
1 / 6 / 4 | No. 643 | No. 1 |
|
||
|
C00037556
|
N-Methyl-calystegine B2
|
CHEMBL447814
|
No. 643 | No. 1 |
|
|||
|
C00036865
|
Calystegine A7
|
No. 643 | No. 1 |
|
||||
|
C00036863
|
Calystegine A5
|
No. 643 | No. 1 |
|
||||
|
C00036864
|
Calystegine A6
|
No. 643 | No. 1 |
|
||||
|
C00036613
|
6-Deoxy-fagomine
/ (-)-6-Deoxy-fagomine |
No. 786 | No. 1 |
|
||||
|
C00002038
|
Fagomine
|
CHEMBL303545
CHEMBL108084 CHEMBL456583 CHEMBL505237 CHEMBL1818435 CHEMBL1818436 CHEMBL1818437 CHEMBL1818438 CHEMBL1818439 |
C105643
|
5 / 9 / 7 | No. 786 | No. 1 |
|
|
|
C00007205
|
(+)-Lyoniresinol
|
CHEMBL455365
CHEMBL1760594 CHEMBL1761710 |
No. 4145 |
|
||||
|
C00012761
|
1,2-Dehydro-alpha-cyperone
/ (+)-Eudesma-1,4,11-trien-3-one / (4aS-cis)-5,6,7,8-Tetrahydro-1,4a-dimethyl-7-(1-methylethenyl)-2(4aH)-naphthalenone |
No. 4452 |
|
|||||
|
C00028498
|
Lyciumin A
|
No. 4771 |
|
|||||
|
C00028433
|
Kukoamine A
|
CHEMBL79129
|
No. 8476 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P04062 | Glucosylceramidase | Enzyme | C00002038 C00035552 C00036866 | 6 / 4 |
| P04066 | Tissue alpha-L-fucosidase | Enzyme | C00002038 | 1 / 2 |
| Q14697 | Neutral alpha-glucosidase AB | Enzyme | C00002038 | 0 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002038 | 1 / 1 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00036313 | 0 / 0 |
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00036313 | 0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00036313 | 7 / 3 |
| Q9P0U3 | Sentrin-specific protease 1 | Enzyme | C00036313 | 0 / 0 |
| P00734 | Prothrombin | S1A | C00036313 | 4 / 2 |
| Q9HCG7 | Non-lysosomal glucosylceramidase | Enzyme | C00002038 | 1 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00036313 | 0 / 0 |
| OMIM | preferred title | UniProt |
|---|---|---|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #230000 | Fucosidosis |
P04066
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
| #613679 | Prothrombin deficiency, congenital |
P00734
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #614409 | Spastic paraplegia 46, autosomal recessive; spg46 |
Q9HCG7
|
| #601367 | Stroke, ischemic |
P00734
|
| #188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
| KEGG | name | UniProt |
|---|---|---|
| H00223 | Inherited thrombophilia |
P00734
(related)
|
| H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00141 | Fucosidosis |
P04066
(related)
|
| H00422 | Glycoproteinoses |
P04066
(related)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|